Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
GZPHF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.8B
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $3.80 Billion |
|---|---|
| Enterprise Value | $15.86 Billion |
| Annual dividend | $0.11 |
| Dividend yield | 3.83% |
| Earnings per Share | $1.82 |
| Beta | 0.18 |
| Outstanding Shares | 1,625,790,949 |
Return
| Return on Equity | 6.51% |
|---|---|
| Return on Assets | 2.90% |
| Return on Invested Capital | 6.10% |
Valuation & Multiples
| P/E Ratio | 12.39 |
|---|---|
| PEG | -22.43 |
| Price to Sales | 0.05 |
| Price to Book Ratio | 0.09 |
| Enterprise Value to Revenue | 0.21 |
| Enterprise Value to EBIT | 5.33 |
| Enterprise Value to Net Income | 6 |
| Total Debt to Enterprise | 1.6 |
| Debt to Equity | 0.65 |
Revenue Sources
No data
Last Earnings Call
Report Date
October 27, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateNext Earnings Call
Expected Date
October 28, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
27,057 employees
CEO: Yuan Cheng
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GBPHCL) is a comprehensive pharmaceutical enterprise focused on the research, development, production, and distribution of a wide array of medical products. These offerings sp...